TransAct Technologies Incorporated TACT
4.87
(0.04)
(0.81%)
as of 25 Sep
- Market cap
- $50.7M
- P/E
- 0.0×
Follow TACT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (1.25%) | (1.56%) | (4.02%) | (23.00%) |
+8 more TTM periods Free account |
|
| (0.84%) | (1.07%) | (2.79%) | (16.89%) | ||
ROIC |
(2.00%) | (2.92%) | (8.28%) | (6.97%) | |
Return on Tangible Assets |
(1.52%) | (1.79%) | (4.59%) | (29.10%) | |
Average Days of Receivables |
71.35 | 62.33 | 45.12 | 42.41 | |
Free Cash Flow per Share |
0.17 | 0.46 | 0.60 | 0.79 | |
Free Cash Flow |
1.76 | 4.73 | 6.06 | 8.00 | |
Capital Expenditures |
(3.69) | (2.16) | (1.61) | (1.45) | |
Piotroski F-Score |
5.00 | 6.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
10.46% | 13.47% | 14.88% | 18.24% | |
Accounts Receivable Turnover |
5.83 | 5.84 | 8.00 | 7.58 | |
Accounts Payable Turnover |
5.97 | 5.93 | 6.53 | 7.57 | |
Inventory Turnover |
2.42 | 2.25 | 1.96 | 1.83 | |
Average Days of Payables |
68.73 | 59.82 | 48.81 | 51.65 | |
Days of Inventory on Hand |
124.17 | 129.75 | 149.75 | 163.67 | |
Tax Rate |
0.42 | 0.35 | 0.14 | 6.05 | |
Research and Development Expense of Revenue |
11.22% | 12.20% | 13.02% | 13.11% | |
Selling, General and Administrative Expense of Revenue |
39.13% | 38.02% | 38.32% | 37.42% | |
Share Based Compensation of Revenue |
3.76% | 3.77% | 3.50% | 3.15% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(13.62) | (13.97) | (6.19) | (1.17) | |
Depreciation/Fixed assets |
0.57 | 0.56 | 0.54 | 0.50 | |
Capex/Depreciation |
(5.92) | (3.29) | (2.40) | (2.07) | |
Revenue per Share |
5.15 | 5.19 | 5.10 | 4.97 | |
Operating CF per Share |
0.53 | 0.68 | 0.76 | 0.94 | |
Capex per Share |
(0.36) | (0.21) | (0.16) | (0.14) | |
Capex to Sales |
0.07 | 0.04 | 0.03 | 0.03 | |
Net Profit Margin |
(0.75%) | (0.93%) | (2.41%) | (16.05%) |
Columns are period end dates